Introduction vascular network within the ovary.
In a prospective, randomized clinical trial the hypothetical Low ovarian response to stimulation in IVF-embryo transfer benefit of withholding GnRH administration upon downpatients occurs in 9-18% of cycles (Pellicer et al., 1987; Scott, regulation combined with high doses of gonadotrophins in 1996), and in most cases results in a cancelled cycle. This is women who previously had insufficient ovarian response to a very frustrating, difficult and disappointing issue of infertility treatment. Inadequate ovarian response carries a low oestradiol complete an IVF attempt was evaluated.
prior to menstruation. Serum oestradiol concentrations of Ͻ60 pg/ml
Materials and methods
(220 pmol/l) and negative findings, i.e. absence of ovarian cysts of Study design Ͼ10 mm on vaginal ultrasound scans, were used to define ovarian This study included a total of 70 IVF cycles performed in 70 low quiescence. If a cyst Ͼ10 mm was observed, serum oestradiol responders treated at our institution between November 1, 1998, and concentrations Ͻ60 pg/ml was sufficient to confirm ovarian quiesFebruary 28, 2000. The study was approved by our institution's ethics cence. If serum oestradiol concentrations were beyond this threshold committee, and all couples were required to sign a written informed value, the patient was excluded from the study. consent after the provision of complete information.
For the high dose, non-stop protocol, a similar approach was used To be included in this study, patients had to have at least one (long protocol) but on days 1 and 2 of ovarian stimulation, three previous cancelled IVF attempt in which fewer than three follicles ampoules of HMG were administered together with five ampoules of ജ18 mm in diameter were obtained and basal FSH concentrations FSH. On days 3, 4 and 5 of ovarian stimulation, two ampoules of were Ͻ12 IU/ml (Karande and Gleicher, 1999) . There were no HMG and thre ampoules of FSH were administered. From day 6 exclusion criteria, nor was there any age limit. The cancelled cycle onward, gonadotrophin dosage was estimated according to serum was stimulated with a standard long protocol, as previously described oestradiol concentrations and transvaginal ovarian ultrasound scans. (Simón et al., 1998) . Briefly, in our standard long protocol, after
Patients included in the stop protocol group received the same pituitary desensitization with leuprolide acetate, 1 mg/day s.c.
gonadotrophin doses as in the high dose, non-stop protocol group. (Procrin; Abbot S.A., Madrid, Spain) on days 1 and 2 of ovarian In both protocols, the criteria for HCG administration (10 000 IU, stimulation, one ampoule of human menopausal gonadotrophin (HMG; Profasi; Serono Laboratories) was the same. The criteria for HCG Lepori; Farma-Lepori Laboratories S.A., Madrid, Spain) was adminisadministration included the presence of at least three follicles tered together with three ampoules of highly purified FSH (Neomeasuring ജ18 mm in diameter. Gonadotrophin administration, and Fertinorm; Serono Laboratories S.A., Madrid, Spain). On days 3, 4 leuprolide acetate in non-stop protocol, were discontinued the day of and 5 of ovarian stimulation, one ampoule of HMG and one ampoule HCG administration. Oocyte retrieval was scheduled for 36-38 h of FSH were given to each patient. Beginning on day 6, HMG and after HCG injection and intravaginal micronized progesterone, 400 FSH were administered on an individual basis according to serum mg/day (Progeffik; Effik Laboratory, Madrid, Spain), was administered oestradiol concentrations and transvaginal ovarian ultrasound scans.
as luteal support. During their next cycle, the patients were informed about the possibility of being included in the study with two study groups (stop IVF/intracytoplasmic sperm injection protocol versus non-stop protocol). Thirty-six patients were treated
The standard IVF/intracytoplasmic sperm injection (ICSI) procedure in 36 cycles with a high dose regimen, whereas 34 were treated in has been described previously Gil-Salom et al., 34 cycles with a stop protocol and a high dose regimen. Successive 1995). Briefly, oocyte-cumulus complexes were evaluated under the ovarian stimulation was separated by a minimum of two or more dissecting microscope and classified. Oocyte-cumulus complexes months in order to avoid any potential source of error, as this is our were incubated at 37°C under 5% CO 2 in atmospheric air. Embryos routine clinical practice.
were scored on the day of transfer according to their morphology under the dissecting microscope. Four types of embryos were established, Assignment and masking ranging from types I to IV. Type I embryos were the best and were Considering low ovarian response to ovarian stimulation as less than defined as round and well-shaped blastomeres without fragments. three oocytes retrieved, the primary endpoint was to at least duplicate The policy for embryo transfer was to select as many type I and type the number of oocytes recovered. For that purpose a prospective II embryos as possible: the remaining embryos were cryopreserved study was designed in which 70 patients were included to be able to with 1,2-propanediol and sucrose. Only patients with freshly transdetect a true effect with this protocol with a probability of 80% ferred embryos were included in the study. The maximum number of (power), being the chances of incorrectly rejecting the null hypothesis embryos transferred was three or four, depending on previous IVF 5% (alpha). Patients were randomized according to a computerized attempts and age of the patient. random number list to either intervention (stop protocol) or control group (non-stop protocol) at the time of previous cycle cancellation.
Hormone measurements Someone not involved in the study performed the randomization. The
Blood was drawn with every transvaginal ovarian ultrasound scan. therapeutic choice was included in consecutively numbered opaque
The samples were stored at -20°C in aliquots for subsequent oestradiol sealed envelopes.
analysis. Serum oestradiol and FSH were analysed using commercially available microparticle enzyme immunoassay kits (Abbot LaboratPatients and stimulation protocol ories, Abbot Park, IL, USA). Inter-and intra-assay variability for The causes of infertility for patients who entered the study were as oestradiol at a concentration of Ͻ40 pg/ml was 2.8 and 4.3%, follows: in 26 cases (37.1%) there was male factor infertility, in respectively, and 4.6 and 6.1% for FSH at a concentration of 22 IU/ml. eight cases (11.4%) tubal infertility, in 15 cases (21.4%) there was unexplained infertility, and in 21 cases (30%) a combination of male Statistical analysis and female factors was present. The aetiology of infertility was Data were expressed as means Ϯ SEM. Comparisons between equally distributed between groups. Mean age of the patients included different cycles of the same patient were performed with the use of in the high dose protocol and in the stop protocol was 34.0 Ϯ 0.5 the Student's t-test, except that pregnancy and implantation rates years and 34.4 Ϯ 0.7 years respectively; body mass index of the were compared with the use of χ 2 -test. When homogeneity and patients included was 21.7 Ϯ 2.5 and 21.9 Ϯ 2.7 kg/m 2 respectively. normality (Kolmogorov-Smirnov test) of the samples were not approThe protocol for ovarian stimulation was initiated with pituitary priate, non-parametric statistical methods (Wilcoxon test) were used desensitization by the administration of leuprolide acetate, 1 mg/day for comparison. P Ͻ 0.05 was considered significant. Statistical s.c. (Procrin; Abbot S.A., Madrid, Spain), starting in the luteal phase calculations were performed using Sigmastat for Windows, version of the previous cycle, on cycle day 21, and this was adjusted according to the length of patient's cycle in order to start the analogue 7 days 2.0 (Jandel Scientific Corporation, San Rafael, CA, USA). 
Results
IVF or ICSI: stop protocol 72.7 Ϯ 4.7% and 79.7 Ϯ 4.3% respectively; non-stop protocol, 74.5 Ϯ 3.9% and 88.6 Ϯ 4.9% Table I presents the data from the study cycle (high dose respectively. gonadotrophins ϩ stop protocol) compared to the high dose, Obviously, a higher number of FSH/HMG ampoules were non-stop cycle, which is our routine practice in low responders administered in the high dose protocol (irrespective of whether with a previous cancelled cycle. Both groups were comparable the patient was included in the stop or non-stop protocol) in terms of age and basal FSH concentrations. when compared to the previous cancelled cycle (62.3 versus When both protocols in the present study were compared 35.5, P Ͻ 0.001). For the same reason, the number of days of (Table I) , it was found that the stop protocol required fewer stimulation (10.7 versus 9.5) as well as the peak oestradiol ampoules of gonadotrophins compared to the non-stop protocol concentration (783.5 versus 367.2 pg/ml) was also higher in (P ϭ 0.013). The mean number of days of FSH/HMG this group. administration was lower in the stop protocol, although the difference did not reach statistical significance. A similar peak of serum oestradiol was found in both protocols. Discussion Table II shows that in patients undergoing ovarian stimulation with the stop protocol a significantly higher number of
The results of this prospective, randomized trial show that early cessation of GnRHa combined with high doses of oocytes was retrieved (8.7 versus 6.2, P ϭ 0.027) as well as a higher number of mature oocytes (6.8 versus 4.1, P ϭ gonadotrophins, although it recruited a significantly higher number of mature oocytes, resulted in similar IVF outcome 0.018). However, similar fertilization and cleavage rates were obtained. Also, the mean number of embryos transferred than a conventional non-stop, long down-regulation protocol. Several mechanisms may contribute to the improved ovarian (2.8 versus 2.6) was similar. No differences were found in cancellation rate (5.8 versus 2.7%), pregnancy rate (18.7 versus response observed with the stop protocol. The pituitary gonadotrophin down-regulation induced by GnRHa decreases cancel-14.3%) and implantation rate between both treatment groups (12.1 versus 8.8%) (Table II) . lation rates by suppressing endogenous LH surges, although this may require significantly higher requirements of gonadoThe number of patients undergoing ICSI was similar in both groups: 90.6% (29/32) of the subjects underwent ICSI in the trophins (Horvarth et al., 1988) , probably due to a direct, partial inhibition of ovarian response, modulating ovarian stop protocol and 85.7% (30/35) in the non-stop protocol. Fertilization rates were similar in both groups, regardless of steroidogenesis and oocyte maturation. A direct inhibitory effect of the GnRHa on the ovaries has been proposed, so tered during the study cycles allowed the recruitment of a higher number of follicles and enabled most women to finish reducing the dose or even stopping the administration would remove this suppression, improving ovarian responsiveness their cycle and undergo oocyte retrieval. Whether the FSH threshold in these women is higher or if the intra-individual (Kowalik et al., 1998) . This hypothesis is based on the presence of GnRH receptors on the ovary (Latouche et al., 1989) . On variability in the ovarian response is responsible for the outcome is something to be determined. the other hand, GnRHa have been proved to decrease blood flow assessed by pulsed Doppler analysis (Aleem and Predanic, The primary efficacy result, i.e. a significantly higher number of mature oocytes, was supported by the fact that the number 1995). Some investigators believe that follicular growth is dependent on an appropriate vascular network responsible for of days of treatment and the dose of FSH required to reach criteria for triggering follicle maturation were both lower for the distribution of circulating gonadotrophins (Zeleznik et al., 1981) . In fact, ovarian blood flow velocity, after pituitary the stop protocol. Gonadotrophin ampoule consumption was lower in the stop protocol, and less GnRHa was used, so the suppression is confirmed, has been shown to be predictive of ovarian responsiveness and the outcome of IVF treatment cost of this cycle in terms of medication is significantly reduced. The reduced gonadotrophin usage together with the (Engmann et al., 1999) . Thus, it could be postulated that GnRHa early cessation, while maintaining pituitary suppreshigher number of mature oocytes retrieved make this protocol appealing, something that would be definitive if it allowed sion, restores the diminished perifollicular blood flow, which correlates with the number of oocytes retrieved and IVF higher pregnancy rates. Although a trend was observed (18.7 versus 14.3%), a prospective study with pregnancy rate as outcome (Bhal et al., 1999) . Whether this is true or not for ovarian vessels in low responders remains to be elucidated.
primary end-goal should be designed to prove this hypothesis. The stop protocol, in spite of having significantly more GnRHa is routinely used until oocyte retrieval, but even with short-acting molecules pituitary down-regulation continues oocytes (8.7 Ϯ 0.9 versus 6.2 Ϯ 0.7), had similar oestradiol concentrations to those observed in the non-stop protocol. In following cessation of GnRHa during ovarian stimulation for IVF (Sungurtekin and Jansen, 1995) . In a recent prospective fact, serum concentrations of oestradiol were higher in the stop protocol, although the values did not reach statistically study, the follicular and luteal phase characteristics following early cessation of GnRHa during ovarian stimulation were significant differences (859.5 Ϯ 132.7 versus 708.6 Ϯ 107.2 pg/ml, P ϭ 0.380), probably due to the limited sample size evaluated (Beckers et al., 2000) . Early follicular phase cessation of GnRHa is still effective in the prevention of a premature of this study. The 'flare effect' derived by the GnRHa administration rise in LH or progesterone, as some pituitary recovery occurred 16-22 days after GnRHa cessation. This is in accordance with during the luteal phase does not seem to be relevant in the ovarian stimulation outcome in this kind of patient. San Roman the fact that most of the cancellations in the study group in the current study as well as in others (Faber et al., 1998; (San Roman et al., 1992) did not find a significant increase in gonadotrophin concentrations in patients receiving GnRHa Dirnfield et al., 1999; Karande and Gleicher, 1999) were not due to a premature ovulation. initiated in the luteal phase opposed to the concentrations found in patients who were initiated with GnRHa during the When the previous cancelled cycles with a conventional IVF protocol were compared using the study cycles (either follicular phase. Consistent findings were described by Gelety (Gelety et al., 1995) . high dose or high dose combined with early cessation of GnRHa) a significant improvement in the ovarian response When clinicians observe a low response to IVF stimulation (less than three follicles), cycle cancellation is usually counwas found. It is interesting to note that regardless of the protocol used, stop or non-stop, we found that a satisfactory selled to the patients, in the hope that a better response might be obtained in a subsequent cycle. This trend is based on the number of oocytes was retrieved in both groups of re-stimulated patients. If it is considered that they were enrolled in this assumption that poor responders have a poor IVF outcome, as they usually have a low oocyte quality. Not all low responders study on the basis of a previous cancelled stimulation with less than three mature follicles, the only explainable hypothesis are the same, as they represent a very heterogeneous group. According to their basal FSH concentrations, young low is the use of high doses of gonadotrophins. Although this explanation appears reasonable, conflicting reports have been responders with high basal FSH concentrations have a poor outcome based on the low quality of the oocytes retrieved. published. Increasing the gonadotrophin dose during the course of treatment was initially advocated by Laufer (Laufer et al., However, young low responders with normal day 3 FSH concentrations, although their ovarian reserve may be com-1986), in an attempt to recruit a higher number of follicles. Several other reports including our data support this approach promised (Pellicer et al., 1998) , might benefit from alternative protocols such as the stop protocol, as their chances of (Chong et al., 1986; Crosignani et al., 1989) . However, other authors have not reported such a beneficial effect (Karande achieving a pregnancy seem to be similar to those of normal responders (Lashen et al., 1999) . and Gleicher, 1990; Van-Hoof et al., 1993; Land et al., 1996) . Patients show a great variability in their ovarian response to It is concluded that low responders with normal basal FSH concentrations may benefit from increasing the doses of the same stimulation protocol, especially those who qualify as poor responders to IVF stimulation, probably based on the gonadotrophins in order to proceed to oocyte retrieval and avoid a new cancelled cycle, with the financial and emotional intercycle variability of basal FSH concentrations (Scott et al., 1990) . Basal day 3 FSH concentrations were comparable implications and frustration for both the patient and physician.
The stop protocol increases the number of available embryos between groups, so it is believed that the higher dose adminis-
